Author: Absci Corporation

Posted Date:

May 4, 2026

Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Absci Corporation

May 4, 2026
Absci to Report Business Updates and First Quarter 2026 Financial and Operating Results on May 7, 2026

Absci Corporation

April 23, 2026
Absci to Participate in the 25th Annual Needham Virtual Healthcare Conference

Absci Corporation

April 8, 2026
Absci Reports Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results

Absci Corporation

March 24, 2026
Absci Launches ABS-201 Endometriosis Advisory Board with Leading Experts from Yale, UCSF, Duke, and the Mayo Clinic

Absci Corporation

March 24, 2026
Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Absci Corporation

March 6, 2026
Absci Strengthens Clinical Leadership with Appointment of Ransi Somaratne, M.D., FACC, MBA as Chief Medical Officer

Absci Corporation

March 3, 2026
Absci to Report Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results on March 24, 2026

Absci Corporation

February 24, 2026
Absci to Participate in Upcoming Investor Conferences

Absci Corporation

February 17, 2026